Arquivamento definitivo - Art. 33 da LPI
#11.1.1
05/31/2022
RPI 2682
Application data
Number
112020010916Type
Filing
Publication
PCT
US2018063719 The application was abandoned: examination was not requested within the 36 months following the 12/04/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 05/31/2022. We update with every new RPI gazette, published weekly.
Applicants
RA PHARMACEUTICALS, INC
US
Inventors
A. R. (pessoa física)
US
M. H. (pessoa física)
US
R. F. (pessoa física)
US
IPC Classification
Priority claims
US
62/594,486 · 12/04/2017
US
62/629,156 · 02/12/2018
US
62/685,314 · 06/15/2018
US
62/769,751 · 11/20/2018
Abstract
A presente invenção refere-se a métodos de tratamento de hemoglobinúria noturna paroxística (PNH) em indivíduos com diferentes exposições a eculizumabe pela administração de R5000. Os métodos incluem métodos de troca de indivíduos do tratamento com eculizumabe para R5000.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
05/31/2022
RPI 2682
#11.1
03/15/2022
RPI 2671
#15.35
12/07/2021
RPI 2657
#1.3
11/17/2020
RPI 2602
#1.1
10/20/2020
RPI 2598
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.